studies devoted to exploration drug controlled release system using such complementary base pairing rules.In this manuscript, a bioinspired temperature response controlled drug release nanosystem based on complementary base pairing rules were designed and prepared (Scheme 1). Just as mentioned above, adenine can form base pairs with thymine through specific A = T hydrogen bond, which fracture under high temperature conditions. Therefore, an adenine modified polydopamine nanoparticle (A-PDA, a photothermal nanoparticle for photothermal therapy (PTT) can be triggered by 808 nm light) and a thymine modified Zinc phthalocyanine (T-ZnPc, an efficient photosensitizer for photodynamic therapy (PDT) can be excited by 665 nm light) were designed and prepared. T-ZnPc can easily assemble on the surface of A-PDA driving for complementary base pairing rules between A and T. Furthermore, Gd 3+ was modified on the surface of above assembled nanoparticles upon simple mixing because Gd 3+ can easily chelate with catechol groups of PDA. [11,12] After assembled on A-PDA nanoparticles surface, the PDT activity was sharply decreased, which could ensure its safety during delivery process. It's well known that polydopamine can absorb near infrared (NIR) irradiation (700-900 nm) to converse thermal with high efficiency. [13][14][15][16] Hence, after being trapped by tumor cells and irradiated by 808 nm light, the photothermal efficacy of A-PDA nanoparticles can not only trigger T-ZnPc release and activation but also provide the PTT induced cell death to synergistic PDT anticancer process of T-ZnPc after 665 nm irradiation. In addition, Gd 3+ in the system can provide magnetic resonance imaging (MRI)-guided delivery and theranostic function. [17,18]
Results and Discussion
Synthesis and Characterization of the A-PDA NanoparticlesAccording to a published literature, dopamine hydrochloride (DA) can self-polymerize under alkaline conditions (deionized water/isopropanol = 8:1, v/v) in the present of oxygen at room temperature. [19] Isopropanol was employed to control the polymerization process of dopamine to obtain PDA nanoparticles since its hindrance effect. PDA nanoparticles can be stable dispersed in water. The formation of PDA nanoparticles Controlled drug release systems can enhance the safety and availability but avoid the side effect of drugs. Herein, the concept of DNA complementary base pairing rules in biology is used to design and prepare a photothermaltriggered drug release system. Adenine (A) modified polydopamine nanoparticles (A-PDA, photothermal reagent) can effectively bind with thymine (T) modified Zinc phthalocyanine (T-ZnPc, photosensitizer) forming A-PDA = T-ZnPc (PATP) complex based on A = T complementary base pairing rules. Similar to DNA, whose base pairing in double strands will break by heating, T-ZnPc can be effectively released from A-PDA after near infrared irradiation-triggered light-thermal conversion to obtain satisfactory photodynamic-photothermal synergistic tumor treatment. In addition, PDA can carry abund...